Press release

CooperVision Announces Sarah Michelle Gellar as Spokesperson to Increase Awareness of Myopia Management and the Brilliant Futures™ Program with MiSight® 1 day Contact Lens

MiSight® 1 day is the first and only FDA-approved* soft contact lens to slow myopia progression in children, ages 8-12 at the initiation of treatment. †¹ SAN

articleThe Cooper Companies, Inc.August 26, 20205/company/the-cooper-companies-inc/news/coopervision-announces-sarah-michelle-gellar-as-spokesperson-to-increase-awareness-of
CooperVision Announces Sarah Michelle Gellar as Spokesperson to Increase Awareness of Myopia Management and the Brilliant Futures™ Program with MiSight® 1 day Contact Lens

About this update from The Cooper Companies, Inc.

[{"type":"text","content":"MiSight® 1 day is the first and only FDA-approved* soft contact lens to slow myopia progression in children, ages 8-12 at the initiation of treatment. †¹\n\n\nSAN RAMON, Calif., Aug. 26, 2020 /PRNewswire/ -- CooperVision, a global leader in myopia management, today announced popular US television actress, producer, and entrepreneur Sarah Michelle Gellar as the spokesperson for its Brilliant Futures™ Myopia Management Program. Brilliant Futures™ is built around MiSight® 1 day, the first and only soft contact lens FDA-approved* to slow the progression of myopia in children ages 8-12 at the initiation of treatment.†1 More than 40% of Americans have myopia, commonly referred to as nearsightedness, and that number is increasing at an alarming rate, especially among school-aged children.2,3\n\n \n \n \n \n \n \n\n \nTwo-thirds of eye care professionals in the United States say the incidence of myopia among children in their practices has increased over the past 5-10 years1 and 81% of those practitioners recognize it as one of the biggest problems impacting children's eyesight today.1 The effects of myopia go beyond the inability to see objects clearly at a distance; worsening myopia may contribute to more severe eye health complications and sight-threatening conditions later in life.1-5\n\"CooperVision received FDA-approval of the MiSight® 1 day contact lens on Nov. 15, 2019, making the United States our 18th market worldwide. This reinforced CooperVision as a leader in the myopia management category,\" said Daniel G. McBride, President of CooperVision. \"In this particular moment in time, with so many children learning virtually and spending less time outdoors, the topic of myopia management is more relevant than ever before. As category creators and leaders in the myopia management sector, we believe it is our responsibility and privilege, alongside the optometric community, to educate parents and offer them tools to help their children who may be struggling with myopia. Our decision to make this sizable investment in educating parents is consistent with our view that addressing myopia early is vitally important.\"\nThis new, multichannel direct-to-consumer advertising campaign featuring Gellar will highlight the importance of annual comprehensive eye exams in monitoring the progression of myopia in children. The campaign will inclu...

More updates from The Cooper Companies, Inc.